Targeted lung cancer screening in the age of immunotherapies and targeted therapies - an economic evaluation for Australia.

Autor: Roseleur J; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Adelaide, Australia., Karnon J; Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Adelaide, Australia., de Koning H; Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands., Milch V; Cancer Australia, Sydney, Australia., Anderson K; Cancer Australia, Sydney, Australia., Real J; Cancer Australia, Sydney, Australia., Keefe D; Cancer Australia, Sydney, Australia., Ten Haaf K; Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publikováno v: The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2024 Nov 25; Vol. 53, pp. 101241. Date of Electronic Publication: 2024 Nov 25 (Print Publication: 2024).

Impact of different age ranges on the benefits and harms of the breast cancer screening programme by the EU-TOPIA tool.

Autor: Pinto-Carbó M; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Vanaclocha-Espí M; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Martín-Pozuelo J; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Romeo-Cervera P; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Hernández-García M; Environmental Health Service, Utiel Public Health Centre, Ministry of Universal and Public Health, Utiel, Valencia Region, Spain., Ibáñez J; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain.; Healthcare Integration Service, Directorate General for Health Care, Regional Ministry of Health, Valencia, Spain., Castán-Cameo S; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain.; Screening Programs Service, General Directorate of Public Health, Regional Ministry of Health, Valencia, Spain., Salas D; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., van Ravesteyn NT; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands., de Koning H; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Zurriaga Ó; Department of Preventive Medicine and Public Health, Food Sciences, Toxicology and Legal Medicine, University of Valencia, Valencia, Spain.; Joint Research Unit on Rare Diseases, FISABIO-University of Valencia (FISABIO-UVEG), Valencia, Spain., Molina-Barceló A; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain.

Publikováno v: European journal of public health [Eur J Public Health] 2024 Aug 01; Vol. 34 (4), pp. 806-811.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The cost-effectiveness of different visual acuity screening strategies in three European countries: a microsimulation study

Autor: Heijnsdijk, E. A. M., Verkleij, M. L., Carlton, J., Horwood, Anna M., Fronius, M., Kik, J., Sloot, F., Vladutiu, C., Simonsz, H. J., de Koning, H. J., The EUSCREEN Foundation

Childhood vision screening programmes in Europe differ by age, frequency and location at which the child is screened, and by the professional who performs the test. The aim of this study is to compare the cost-effectiveness for three countries with d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::a7e0037c814c2c955c95dd81d245a63b
https://centaur.reading.ac.uk/105937/3/1-s2.0-S2211335522001759-main.pdf

Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.

Autor: Lam S; Department of Integrative Oncology, British Columbia Cancer Research Institute, Vancouver, British Columbia, Canada; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: slam2@bccancer.bc.ca., Bai C; Shanghai Respiratory Research Institute and Chinese Alliance Against Cancer, Shanghai, People's Republic of China., Baldwin DR; Nottingham University Hospitals National Health Services (NHS) Trust, Nottingham, United Kingdom., Chen Y; Digital Screening, Faculty of Medicine & Health Sciences, University of Nottingham Medical School, Nottingham, United Kingdom., Connolly C; International Association for the Study of Lung Cancer, Denver, Colorado., de Koning H; Department of Public Health, Erasmus MC University Medical Centre Rotterdam, The Netherlands., Heuvelmans MA; University of Groningen, Groningen, The Netherlands; Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands; The Institute for Diagnostic Accuracy, Groningen, The Netherlands., Hu P; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Kazerooni EA; Division of Cardiothoracic Radiology, Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan., Lancaster HL; University of Groningen, Groningen, The Netherlands; Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands; The Institute for Diagnostic Accuracy, Groningen, The Netherlands., Langs G; Computational Imaging Research Laboratory, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria., McWilliams A; Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia; Australia University of Western Australia, Nedlands, Western Australia., Osarogiagbon RU; Thoracic Oncology Research Group, Baptist Cancer Center, Memphis, Tennessee., Oudkerk M; Center for Medical Imaging and The Institute for Diagnostic Accuracy, Faculty of Medical Sciences, University of Groningen, Groningen, The Netherlands., Peters M; Woolcock Institute of Respiratory Medicine, Macquarie University, Sydney, New South Wales, Australia., Robbins HA; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France., Sahar L; Data Science, American Cancer Society, Atlanta, Georgia., Smith RA; Early Cancer Detection Science, American Cancer Society, Atlanta, Georgia., Triphuridet N; Department of Medicine, Chulabhorn Hospital, Bangkok, Thailand., Field J; Department of Molecular and Clinical Cancer Medicine, The University of Liverpool, Liverpool, United Kingdom.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Jan; Vol. 19 (1), pp. 36-51. Date of Electronic Publication: 2023 Jul 23.